BTG PLC (BTG.L)

BTG.L on London Stock Exchange

696.00GBp
21 Oct 2014
Price Change (% chg)

-3.00p (-0.43%)
Prev Close
699.00p
Open
693.50p
Day's High
701.00p
Day's Low
685.50p
Volume
550,901
Avg. Vol
577,270
52-wk High
738.00p
52-wk Low
400.00p

BTG.L

Chart for BTG.L

About

BTG plc is an international specialist healthcare company. The Company is focused on three business areas: Specialty Pharmaceuticals, Interventional Medicine and Licensing & Biotechnology. Its focus within Specialty Pharmaceuticals is on antidote products that are used within hospitals. Its interventional medicine products are... (more)

Overall

Beta: 0.33
Market Cap (Mil.): £2,608.56
Shares Outstanding (Mil.): 362.80
Dividend: --
Yield (%): --

Financials

  BTG.L Industry Sector
P/E (TTM): 104.84 33.21 34.06
EPS (TTM): 0.07 -- --
ROI: 4.41 18.18 17.45
ROE: 5.04 18.85 18.26
Search Stocks

BRIEF-BTG to supply DC Bead, Bead Block directly to doctors in Europe

* To supply DC Bead and Bead Block directly to physicians in Europe from 1 April 2015

13 Oct 2014

BRIEF-BTG settles Crofab patent litigation case against Bioclon, RDT

* BTG would allow Bioclon to begin selling crotalid antivenom relying on BTG's 414 patent from October 2018

10 Oct 2014

BRIEF-BTG receives FDA nod for pulmonary embolism treatment

* Ekosonic endovascular system receives FDA clearance for treatment of pulmonary embolism in USA Source text for Eikon: Further company coverage:

23 May 2014

BRIEF-BTG full-year pretax profit rises 38 pct

* FY pretax profit 33.3 million stg versus 24.1 million stg year ago

20 May 2014

Earnings vs. Estimates

Search Stocks